What to do now? Sorry but sell TAVR tech for $25m but keep the adapt business to supply the material for the TAVR as a contract. That way we supply adapt for the TAVR and in my opinion for the market leader for Mitral Valve 4C valve. Either of these could sell in the 20000s per year and we may sell them at $3000 per valve with a 50% margin. Forget TAVR outright ownership unfortunately with the present debacle but move on and survive. As well sell Vaccine 29 % and the infusion business and supply the two above projects with cash in hand. We could then have our 3D aortic valve to supply to the world as a separate business. WP go for broke and return this SP to multiples of its present position . The Adapt supply for the TAVR and MAVR could be worth 120m per year with a 50% margin so go for this instead of aiming for the moon and TAVR ownership in our present state and recent non achievements.
What to do now? Sorry but sell TAVR tech for $25m but keep the...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.035(0.19%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.00 | $17.65 | $75.19K | 4.184K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 414 | $17.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |